Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

76.4K
Overview
76.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

583
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
583
Tissue Transplantation01:24

Tissue Transplantation

632
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
632
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.5K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.5K
Hematopoiesis01:21

Hematopoiesis

7.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes.

Clinical immunology communications·2026
Same author

Risk factors for alloimmune lung syndromes after allogeneic hematopoietic cell transplantation in children.

Bone marrow transplantation·2026
Same author

Single-cell multiomic atlas of healthy pediatric bone marrow reveals age-dependent differences in lineage differentiation driven by stromal signaling.

Nature immunology·2026
Same author

Real-world evaluation of isavuconazole in children with cancer.

The Journal of antimicrobial chemotherapy·2026
Same author

Protocol for modeling the repair of intestinal damage by co-culturing mesenchymal stromal/stem cells and intestinal organoids.

STAR protocols·2025
Same author

Posttransplantation clonal dynamics of hematopoietic stem cells carrying prenatal and early-life <i>DNMT3A</i> mutations.

HemaSphere·2025

Related Experiment Video

Updated: Oct 22, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.0K

Hematopoietic Dysfunction during Graft-Versus-Host Disease: A Self-Destructive Process?

Konradin F Müskens1, Caroline A Lindemans1,2, Mirjam E Belderbos1

  • 1Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Cells
|August 27, 2021
PubMed
Summary

Graft-versus-host disease (GvHD) impairs blood cell production after stem cell transplants. This review details how GvHD and related issues damage the bone marrow, affecting patient recovery.

Keywords:
bone marrow nichecytopeniagraft failuregraft-versus-host diseasehematopoiesishematopoietic stem cell transplantationpoor graft function

More Related Videos

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.7K
Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

7.3K

Related Experiment Videos

Last Updated: Oct 22, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.0K
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.7K
Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

7.3K

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Graft-versus-host disease (GvHD) is a significant complication following allogeneic hematopoietic stem cell transplantation (HCT).
  • GvHD leads to severe, prolonged hematopoietic dysfunction, contributing to high mortality rates.
  • Immune activation in GvHD damages hematopoietic stem/progenitor cells and the bone marrow niche, reducing cell number and function.

Purpose of the Study:

  • To provide a structured overview of GvHD-mediated hematopoietic dysfunction.
  • To identify targets within the bone marrow affected by GvHD.
  • To elucidate the mechanisms of action and the impact of GvHD-related complications and their treatments.

Main Methods:

  • This is a review article.
  • Literature search and synthesis of existing research on GvHD and hematopoietic dysfunction.
  • Analysis of mechanisms targeting bone marrow stem cells and niche.

Main Results:

  • GvHD directly damages hematopoietic stem and progenitor cells and the bone marrow microenvironment.
  • Hematopoietic dysfunction is exacerbated by immunosuppressive therapy, infections, and microbiome alterations associated with HCT.
  • Specific targets and mechanisms of GvHD-induced damage are detailed.

Conclusions:

  • Understanding GvHD's impact on hematopoiesis is crucial for improving patient outcomes.
  • Identifying mechanisms of damage can guide the development of novel therapeutic strategies.
  • Targeting GvHD and its complications may restore hematopoietic function post-HCT.